Literature DB >> 15757791

Toxic myopathies.

Ronan J Walsh1, Anthony A Amato.   

Abstract

Muscle tissue is highly sensitive to drugs and toxins because ot its high metabolic activity and potential sites for disruption of energy-producing pathways. Early recognition of toxic myopathies is important, as they potentially are reversible on removal of the offending toxin, with greater likelihood of complete resolution the sooner this is achieved. Clinical features range from mild muscle pain and cramps to severe weakness with rhabdomyolysis, renal failure, and even death. The pathogenic bases can be multifactorial. This article reviews drugs responsible for common types of toxic myopathy and their clinical and histopathologic features and illustrates possible underlying cellular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757791     DOI: 10.1016/j.ncl.2004.12.014

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  6 in total

1.  Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications.

Authors:  Jim S Wu; Catherine Buettner; Howard Smithline; Long H Ngo; Robert L Greenman
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

Review 2.  [Medically induced myopathia].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 3.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

4.  Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; Lan Wu; Gulnara Mamyrova; Ira N Targoff; Frederick W Miller
Journal:  Rheumatology (Oxford)       Date:  2010-08-27       Impact factor: 7.580

Review 5.  Syphilitic myositis: a case-based review.

Authors:  Elaine Yacyshyn; Praveena Chiowchanwisawakit; Derek J Emery; Jack Jhamandas; Lothar Resch; Geoffrey Taylor
Journal:  Clin Rheumatol       Date:  2011-01-07       Impact factor: 3.650

6.  Anabolic androgenic steroid induced necrotising myopathy.

Authors:  Michael Hughes; Saleh Ahmed
Journal:  Rheumatol Int       Date:  2009-10-27       Impact factor: 2.631

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.